ICYMI, this week we had stories from the trending skin care from May, FDA's newest pipeline move, and more.
Dermatopathologists diagnose melanoma at similar rates regardless of whether they think the skin cancer is overdiagnosed.
There is room for improvement in dermatology palliative care; training can help providers raise that standard.
The AAD recently added topical tirbanibulin (Klisyri: Almirall) to its list of recommended therapies for treating AK.
In this month’s “Meet the Aesthetic Expert” column, Will Kirby, DO, FAOCD, talks with Ryan Greene, MD, PhD, FACS, about how this board-certified facial plastic surgeon applies his expertise to non-surgical aesthetics and what that means for improving outcomes with injectables and other minimally invasive techniques.
Dupilumab (Dupixent; Sanofi and Regeneron Pharmaceuticals, Inc) has received priority review for its supplemental Biologics License Application by the FDA to treat adult patients with prurigo nodularis.
Timber Pharmaceuticals has received an FDA breakthrough therapy designation for TMB-001 for the treatment of congenital ichthyosis.
This week's edition of the Mainstream Patients features stories about heat rash, drinking Aloe Vera juice, and more.
Each month, Dermatology Times® features a roundup of products trending in skin care. Click here to find out what products are trending for the month of May.
Take a world tour of the global game-changing advances and home-grown success strategies dermatologists in the United States and abroad are using to tackle the challenges of acne.
An expert takes a look at both modalities in treating acne scarring, wrinkles, pigmentation issues, and actinic keratoses.
Investigators explore the effectiveness of new combination therapies to address the multifactorial pathophysiology of acne vulgaris.
Two new studies analyzes the competencies and limitations of teaching a neural network to recognize facial acne.
In this month's Legal Eagle, David J. Goldberg, MD, JD, writes about the legal burden of having a chaperone during skin exams.
In this month's Cosmetic Conundrums, Zoe Diana Draelos, MD, tackles the issues of hair loss after pregnancy, the role of pH in hair care, hair strengthening conditioner, and more.
Approximately 36% of all physicians will be sued at least once before they are aged 45 years.
Fresh spins on established treatments and newly FDA-approved drugs and devices provide a framework for changing therapies and modalities for acne regimens.
Regeneron Pharmaceuticals Inc came to an agreement to buy the drug from Sanofi for up to $1.1 billion.
Offering in-person and virtual formats, the 2022 PA & NP Fall Clinical Dermatology Conference includes 3 days of informative sessions designed to help health care practitioners “unlock their value to their patients and their practice.
Darrell S. Rigel highlights what to expect for the 2022 PA&NP Fall Clinical Conference happening June 3 to 5 in Scottsdale, Arizona.